Analyst Profile

Followed by 1,670 followers
.
Irina Rivkind Koffler

Irina Rivkind Koffler

Mizuho Securities
Wall Street Analyst
#7,599 out of 8,170 Wall Street Analysts
#22,926 out of 24,551 experts

Success Rate

35%
116 out of 329 transactions made a profit

Average Return

-5.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Irina Rivkind Koffler's trades since 2012 and holding each position for 1 Year would result in 35.26% of your transactions generating a profit, with an average return of -5.0% per rating.

Stock Rating Distribution

946Ratings
53.38% Buy
37.95% Hold
8.67% Sell
Distribution of Irina Rivkind Koffler's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Eagle Pharmaceuticals
(EGRX)
Rating:Buy
Date:Dec 18, 2014 - Dec 18, 2015
Return:+638.90%
The most profitable rating made by Irina Rivkind Koffler

Irina Rivkind Koffler's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
MRX
Medicis Pharmaceutical
Sep 04, 2012
Hold
Reiterated
2Ratings
0.00%
OMPI
Obagi Medical Products
Mar 21, 2013
Hold
Downgraded
4Ratings
0.00%
WCRX
Warner Chilcott
Aug 22, 2013
Buy
Assigned
6Ratings
0.00%
~FRX
Forest Labs
Feb 18, 2014
Hold
Downgraded
6Ratings
0.00%
Assembly Biosciences
Aug 18, 2014
Hold
Reiterated
$6.50
(480.36% Upside)
8Ratings
0.00%
Seelos Therapeutics
Oct 28, 2014
Hold
Downgraded
$1.50
(35.14% Upside)
4Ratings
0.00%
CBST
Cubist Pharma
Dec 08, 2014
Hold
Reiterated
11Ratings
0.00%
SLXP
Salix
Jan 29, 2015
Buy
Reiterated
15Ratings
100%
+49.10%
PTXTQ
Pernix Therapeutics
May 04, 2015
Hold
Reiterated
11Ratings
0%
-2.90%
HPTX
Hyperion Therapeutics
May 07, 2015
Hold
Assigned
7Ratings
100%
+55.30%
List of latest recommendations made by Irina Rivkind Koffler. Click to expand and see Irina Rivkind Koffler's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >